Medical Polymer Market–Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 – 2025
The report covers the analysis and forecast of the biopolymer market on global as well as regional level. The study provides historic data of 2016 along with the forecast for the period between 2017 and 2025 based on revenue (US$ Mn).
The study provides a detailed view of the medical polymer market, by segmenting it based on product type, end-use and regional demand. The medical polymer market consists of the growing category of pharmaceutical device demand. Omnipresence of cardiovascular problems, infections, and other diseases, coupled with increasing evolution of medical treatments and procedures and increasing general awareness of people will fuel the pharmaceutical device industry in the upcoming years. The different types of biopolymers products prevailing in the market include Fibers & resins (PVC, PP, PE, and PS), Medical elastomer, biodegradable medical polymer and others. Medical Polymer products are typically irregular in shape under microscopic examination but also has the potential in creating a massive prospective market for various applications. Huge demand of polymers in the medical industry creates a high growth opportunity of this product during the forecast period of 2017-2025.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The segmentation also includes demand of the product and applications in all regions.
The competitive profiling of the key players in the global biopolymer market across five broad geographic regions is included in the study. These include different business strategies adopted by the leading players and their recent developments, as in the field of biopolymer market.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the medical polymer market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the medical polymer market.
The report provides the size of the biopolymer market from 2016 and the forecast for the next nine years up to 2025. The size of the global medical polymer product is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Middle East and Africa, and Asia Pacific have been taken into account in estimating the growth of the global market.
The Market estimates for this study have been based on revenue being derived through regional pricing trends. Demand for medical polymer has been derived by analyzing the global and regional demand for medical polymer in each application for its respective functions. The medical polymer market has been analyzed based on expected demand.Forecasts have been based on expected demand from medical polymer applications. We have used the bottom-up approach to estimate the global revenue of the medical polymer market, split into regions. Based on product type, and end-use, we have summed up the individual revenues from all the regions to achieve the global revenue for medical polymer. The application split of the market has been derived using a bottom-up approach for each regional market separately, with the global application segment split being an integration of regional estimates. Various Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of polymer several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence across all applications.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include bayermaterialscience AG, BASF SE, Celanese Corporation, E.I. DU PONT, Eastman Chemical Company, Dow chemical and so on.
The global medical polymer market has been segmented into:
Global Medical Polymer Market: By Geography
The study provides a detailed view of the medical polymer market, by segmenting it based on product type, end-use and regional demand. The medical polymer market consists of the growing category of pharmaceutical device demand. Omnipresence of cardiovascular problems, infections, and other diseases, coupled with increasing evolution of medical treatments and procedures and increasing general awareness of people will fuel the pharmaceutical device industry in the upcoming years. The different types of biopolymers products prevailing in the market include Fibers & resins (PVC, PP, PE, and PS), Medical elastomer, biodegradable medical polymer and others. Medical Polymer products are typically irregular in shape under microscopic examination but also has the potential in creating a massive prospective market for various applications. Huge demand of polymers in the medical industry creates a high growth opportunity of this product during the forecast period of 2017-2025.
Regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. The segmentation also includes demand of the product and applications in all regions.
The competitive profiling of the key players in the global biopolymer market across five broad geographic regions is included in the study. These include different business strategies adopted by the leading players and their recent developments, as in the field of biopolymer market.
A comprehensive analysis of the market dynamics that is inclusive of market drivers, restraints, and opportunities is part of the report. Additionally, the report includes potential opportunities in the medical polymer market at the global and regional levels. Market dynamics are the factors which impact the market growth, so their analysis helps understand the ongoing trends of the global market. Therefore, the report provides the forecast of the global market for the period from 2017 to 2025, along with offering an inclusive study of the medical polymer market.
The report provides the size of the biopolymer market from 2016 and the forecast for the next nine years up to 2025. The size of the global medical polymer product is provided in terms of revenue. Market revenue is defined in US$ Mn. The market dynamics prevalent in North America, Europe, Middle East and Africa, and Asia Pacific have been taken into account in estimating the growth of the global market.
The Market estimates for this study have been based on revenue being derived through regional pricing trends. Demand for medical polymer has been derived by analyzing the global and regional demand for medical polymer in each application for its respective functions. The medical polymer market has been analyzed based on expected demand.Forecasts have been based on expected demand from medical polymer applications. We have used the bottom-up approach to estimate the global revenue of the medical polymer market, split into regions. Based on product type, and end-use, we have summed up the individual revenues from all the regions to achieve the global revenue for medical polymer. The application split of the market has been derived using a bottom-up approach for each regional market separately, with the global application segment split being an integration of regional estimates. Various Companies were considered for the market share analysis, based on their innovation and application and revenue generation. In the absence of specific data related to the sales of polymer several privately held companies, calculated assumptions have been made in view of the company’s penetration and regional presence across all applications.
The report covers a detailed competitive outlook that includes the market share and company profiles of key players operating in the global market. Key players profiled in the report include bayermaterialscience AG, BASF SE, Celanese Corporation, E.I. DU PONT, Eastman Chemical Company, Dow chemical and so on.
The global medical polymer market has been segmented into:
Global Medical Polymer Market: By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Italy
- France
- Germany
- Russia
- Spain
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia
- Rest of Asia Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- Latin America
- Brazil
- Rest of Latin America
- Implants
- Diagnostic System
- Hospital Accessories
- Fibers & Resins
- PVC
- PP
- PE
- PS
- Medical Elastomer
- Biodegradable Medical Polymer
1 INTRODUCTION
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF MEDICAL POLYMER MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL MEDICAL POLYMER MARKET SNAPSHOT
3.2 GLOBAL MEDICAL POLYMER MARKET REVENUE, 2016 – 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL MEDICAL POLYMER MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 FIBERS & RESINS
5.2.1 PVC
5.2.2 PP
5.2.3 PE
5.2.4 PS
5.3 MEDICAL ELASTOMERS
5.4 BIODEGRADABLE MEDICAL POLYMERS
6 GLOBAL MEDICAL POLYMER MARKET, BY END-USE
6.1 OVERVIEW
6.2 IMPLANTS
6.3 DIAGNOSTIC SYSTEM
6.4 HOSPITAL ACCESSORIES
7 GLOBAL MEDICAL POLYMER MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 ITALY
7.2.3 U.K
7.2.4 RUSSIA
7.2.5 SPAIN
7.2.6 FRANCE
7.2.7 GERMANY
7.2.8 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 AUSTRALIA
7.3.3 INDIA
7.3.4 CHINA
7.3.5 JAPAN
7.3.6 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 GCC
7.4.3 SOUTH AFRICA
7.4.4 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 COMPETATIVE LANDSCAPE
8.1 OVERVIEW
8.2 NEW PRODUCT LAUNCHES
9 GLOBAL MEDICAL POLYMER MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 BAYERMATERIALSCIENCE AG
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 BASF SE
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 CELANESE CORPORATION
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 DSM N.V.
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 E.I. DU PONT DE NEMOURS COMPANY
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 EASTMAN CHEMICAL COMPANY
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 EVONIK INDUSTRIES AG
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 EXXONMOBIL CORPORATION
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 DOW CHEMICAL COMPANY
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS
1.1 MARKET SEGMENTATION
2 RESEARCH METHODOLOGY
2.1 ECOSYSTEM OF MEDICAL POLYMER MARKET
2.2 TOP-DOWN APPROACH
2.3 BOTTOM-UP APPROACH
2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 GLOBAL MEDICAL POLYMER MARKET SNAPSHOT
3.2 GLOBAL MEDICAL POLYMER MARKET REVENUE, 2016 – 2025(US$ MN)
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 KEY TRENDS ANALYSIS
4.3 PRODUCT DEVELOPMENT AND DIVERSIFICATION ANALYSIS
4.4 PORTERS FIVE FORCE ANALYSIS
4.5 VALUE CHAIN ANALYSIS
4.6 COMPETITIVE LANDSCAPE
4.7 COMPANY MARKET SHARE ANALYSIS
4.8 EXPANSION STRATEGIES ADOPTED BY LEADING PLAYERS
5 GLOBAL MEDICAL POLYMER MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 FIBERS & RESINS
5.2.1 PVC
5.2.2 PP
5.2.3 PE
5.2.4 PS
5.3 MEDICAL ELASTOMERS
5.4 BIODEGRADABLE MEDICAL POLYMERS
6 GLOBAL MEDICAL POLYMER MARKET, BY END-USE
6.1 OVERVIEW
6.2 IMPLANTS
6.3 DIAGNOSTIC SYSTEM
6.4 HOSPITAL ACCESSORIES
7 GLOBAL MEDICAL POLYMER MARKET, BY GEOGRAPHY
7.1 NORTH AMERICA
7.1.1 MARKET DYNAMICS
7.1.1.1 DRIVERS
7.1.1.2 RESTRAINS
7.1.1.3 OPPORTUNITY
7.1.2 U.S.
7.1.3 CANADA
7.1.4 MEXICO
7.2 EUROPE
7.2.1 MARKET DYNAMICS
7.2.1.1 DRIVERS
7.2.1.2 RESTRAINS
7.2.1.3 OPPORTUNITY
7.2.2 ITALY
7.2.3 U.K
7.2.4 RUSSIA
7.2.5 SPAIN
7.2.6 FRANCE
7.2.7 GERMANY
7.2.8 REST OF EUROPE
7.3 ASIA PACIFIC
7.3.1 MARKET DYNAMICS
7.3.1.1 DRIVERS
7.3.1.2 RESTRAINS
7.3.1.3 OPPORTUNITY
7.3.2 AUSTRALIA
7.3.3 INDIA
7.3.4 CHINA
7.3.5 JAPAN
7.3.6 REST OF ASIA PACIFIC
7.4 MIDDLE EAST AND AFRICA
7.4.1 MARKET DYNAMICS
7.4.1.1 DRIVERS
7.4.1.2 RESTRAINS
7.4.1.3 OPPORTUNITY
7.4.2 GCC
7.4.3 SOUTH AFRICA
7.4.4 REST OF MIDDLE EAST AND AFRICA
7.5 LATIN AMERICA
7.5.1 MARKET DYNAMICS
7.5.1.1 DRIVERS
7.5.1.2 RESTRAINS
7.5.1.3 OPPORTUNITY
7.5.2 BRAZIL
7.5.3 REST OF LATIN AMERICA
8 COMPETATIVE LANDSCAPE
8.1 OVERVIEW
8.2 NEW PRODUCT LAUNCHES
9 GLOBAL MEDICAL POLYMER MARKET, BY COMPANY
9.1 INTRODUCTION
9.2 BAYERMATERIALSCIENCE AG
9.2.1 BUSINESS OVERVIEW
9.2.2 PRODUCTS & SERVICES
9.2.3 KEY STRATEGY
9.2.4 RECENT DEVELOPMENTS
9.2.5 SWOT ANALYSIS
9.3 BASF SE
9.3.1 BUSINESS OVERVIEW
9.3.2 PRODUCTS & SERVICES
9.3.3 KEY STRATEGY
9.3.4 RECENT DEVELOPMENTS
9.3.5 SWOT ANALYSIS
9.4 CELANESE CORPORATION
9.4.1 BUSINESS OVERVIEW
9.4.2 PRODUCTS & SERVICES
9.4.3 KEY STRATEGY
9.4.4 RECENT DEVELOPMENTS
9.4.5 SWOT ANALYSIS
9.5 DSM N.V.
9.5.1 BUSINESS OVERVIEW
9.5.2 PRODUCTS & SERVICES
9.5.3 KEY STRATEGY
9.5.4 RECENT DEVELOPMENTS
9.5.5 SWOT ANALYSIS
9.6 E.I. DU PONT DE NEMOURS COMPANY
9.6.1 BUSINESS OVERVIEW
9.6.2 PRODUCTS & SERVICES
9.6.3 KEY STRATEGY
9.6.4 RECENT DEVELOPMENTS
9.6.5 SWOT ANALYSIS
9.7 EASTMAN CHEMICAL COMPANY
9.7.1 BUSINESS OVERVIEW
9.7.2 PRODUCTS & SERVICES
9.7.3 KEY STRATEGY
9.7.4 RECENT DEVELOPMENTS
9.7.5 SWOT ANALYSIS
9.8 EVONIK INDUSTRIES AG
9.8.1 BUSINESS OVERVIEW
9.8.2 PRODUCTS & SERVICES
9.8.3 KEY STRATEGY
9.8.4 RECENT DEVELOPMENTS
9.8.5 SWOT ANALYSIS
9.9 EXXONMOBIL CORPORATION
9.9.1 BUSINESS OVERVIEW
9.9.2 PRODUCTS & SERVICES
9.9.3 KEY STRATEGY
9.9.4 RECENT DEVELOPMENTS
9.9.5 SWOT ANALYSIS
9.10 DOW CHEMICAL COMPANY
9.10.1 BUSINESS OVERVIEW
9.10.2 PRODUCTS & SERVICES
9.10.3 KEY STRATEGY
9.10.4 RECENT DEVELOPMENTS
9.10.5 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 GLOBAL MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 2 GLOBAL MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 3 GLOBAL MEDICAL POLYMER MARKET, BY END-USE
TABLE 4 NEW PRODUCT LAUNCHES, 2016-2025
TABLE 5 NORTH AMERICA MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 6 NORTH AMERICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 7 NORTH AMERICA MEDICAL POLYMER MARKET, BY END-USE
TABLE 8 EUROPE MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 9 EUROPE MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 10 EUROPE MEDICAL POLYMER MARKET, BY END-USE
TABLE 11 ASIA-PACIFIC MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 12 ASIA-PACIFIC MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 13 ASIA-PACIFIC MEDICAL POLYMER MARKET, BY END-USE
TABLE 14 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 15 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 16 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET, BY END-USE
TABLE 17 LATIN AMERICA MEDICAL POLYMERMARKET SIZE, 2016-2025 (USD MN)
TABLE 18 LATIN AMERICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 19 LATIN AMERICA MEDICAL POLYMER MARKET, BY END-USE
TABLE 1 GLOBAL MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 2 GLOBAL MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 3 GLOBAL MEDICAL POLYMER MARKET, BY END-USE
TABLE 4 NEW PRODUCT LAUNCHES, 2016-2025
TABLE 5 NORTH AMERICA MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 6 NORTH AMERICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 7 NORTH AMERICA MEDICAL POLYMER MARKET, BY END-USE
TABLE 8 EUROPE MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 9 EUROPE MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 10 EUROPE MEDICAL POLYMER MARKET, BY END-USE
TABLE 11 ASIA-PACIFIC MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 12 ASIA-PACIFIC MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 13 ASIA-PACIFIC MEDICAL POLYMER MARKET, BY END-USE
TABLE 14 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET SIZE, 2016-2025 (USD MN)
TABLE 15 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 16 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET, BY END-USE
TABLE 17 LATIN AMERICA MEDICAL POLYMERMARKET SIZE, 2016-2025 (USD MN)
TABLE 18 LATIN AMERICA MEDICAL POLYMER MARKET, BY PRODUCT TYPE
TABLE 19 LATIN AMERICA MEDICAL POLYMER MARKET, BY END-USE
LIST OF FIGURES
FIGURE 1 MARKET SEGMENT
FIGURE 2 MARKET INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 NORTH AMERICA MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 6 SWOT ANALYSIS
FIGURE 7 EUROPE MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 8 ASIA-PACIFIC MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 9 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 10 LATIN AMERICA MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 1 MARKET SEGMENT
FIGURE 2 MARKET INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 BOTTOM-UP APPROACH
FIGURE 5 NORTH AMERICA MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 6 SWOT ANALYSIS
FIGURE 7 EUROPE MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 8 ASIA-PACIFIC MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 9 MIDDLE EAST AND AFRICA MEDICAL POLYMER MARKET SNAPSHOT
FIGURE 10 LATIN AMERICA MEDICAL POLYMER MARKET SNAPSHOT
